

The identification of two H3.3 mutations allow the categorization of pediatric brain cancer patients into patients with grade IV pediatric GBM (P<0.0001) and grade III pediatric anaplastic astrocytoma (p<0.0078) and diffuse intrinsic diffuse intrinsic pontine gliomas. Occurrence of these mutations is linked to lower survival rate and help physicians in the clinical decision making process.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog